Lillian Aldaia, MD
Cardiovascular Disease · Morristown, NJNPI 1912167297
Payments from drug & device makers
What this record shows
Edwards Lifesciences accounts for 86.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $1,048 and has fallen 90.2% since, to $103 in 2024. That places this record below the midpoint for cardiovascular disease clinicians in NJ, where the typical reported total is $2,633.
Across 28 payments — averaging $44.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$1K
- Novartis$69
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$43
- Pfizer$34
- Abbott$12
- Medtronic$11
What the payments were for
- Travel & lodging$56146%
- Food & beverage$67254%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 15 | $1,064 |
| Novartis | 4 | $69 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $43 |
| Pfizer | 2 | $34 |
| Abbott | 1 | $12 |
| Medtronic | 1 | $11 |
How this compares
$1,234 in reported general payments places this provider in the 30th percentile of 1,006 cardiovascular disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 12 | $7,533 |
| Metoprolol Succinate | 26 | $371 |
| Rosuvastatin Calcium | 21 | $239 |
| Losartan Potassium | 17 | $188 |
| Amlodipine Besylate | 15 | $159 |
| Atorvastatin Calcium | 11 | $122 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Morristown
- Gennaro GiustinoMorristown$135K
- Konstantinos KoulogiannisMorristown$123K
- Linda GillamMorristown$61K
- Robert KippermanMorristown$48K
- Marc CohenNewark$762K
- Peter FarrugiaColts Neck$600K
- Felix Dailey-SterlingGuttenberg$568K
- Ramzan ZakirNew Brunswick$342K
- Richard KovachBrowns Mills$300K
- Andrea RussoCamden$293K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.